363 related articles for article (PubMed ID: 16868543)
1. Methotrexate used in combination with aminolaevulinic acid for photodynamic killing of prostate cancer cells.
Sinha AK; Anand S; Ortel BJ; Chang Y; Mai Z; Hasan T; Maytin EV
Br J Cancer; 2006 Aug; 95(4):485-95. PubMed ID: 16868543
[TBL] [Abstract][Full Text] [Related]
2. Methotrexate enhances 5-aminolevulinic acid-mediated photodynamic therapy-induced killing of human SCC4 cells by upregulation of coproporphyrinogen oxidase.
Yang DF; Lee JW; Chen HM; Huang Z; Hsu YC
J Formos Med Assoc; 2014 Feb; 113(2):88-93. PubMed ID: 24485831
[TBL] [Abstract][Full Text] [Related]
3. Low-dose methotrexate enhances aminolevulinate-based photodynamic therapy in skin carcinoma cells in vitro and in vivo.
Anand S; Honari G; Hasan T; Elson P; Maytin EV
Clin Cancer Res; 2009 May; 15(10):3333-43. PubMed ID: 19447864
[TBL] [Abstract][Full Text] [Related]
4. Topical methotrexate pretreatment enhances the therapeutic effect of topical 5-aminolevulinic acid-mediated photodynamic therapy on hamster buccal pouch precancers.
Yang DF; Lee JW; Chen HM; Hsu YC
J Formos Med Assoc; 2014 Sep; 113(9):591-9. PubMed ID: 24811932
[TBL] [Abstract][Full Text] [Related]
5. Differentiation-specific increase in ALA-induced protoporphyrin IX accumulation in primary mouse keratinocytes.
Ortel B; Chen N; Brissette J; Dotto GP; Maytin E; Hasan T
Br J Cancer; 1998 Jun; 77(11):1744-51. PubMed ID: 9667642
[TBL] [Abstract][Full Text] [Related]
6. The inhibition of ferrochelatase enhances 5-aminolevulinic acid-based photodynamic action for prostate cancer.
Fukuhara H; Inoue K; Kurabayashi A; Furihata M; Fujita H; Utsumi K; Sasaki J; Shuin T
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):399-409. PubMed ID: 24284092
[TBL] [Abstract][Full Text] [Related]
7. Photodynamic effects of 5-aminolevulinic acid and its hexylester on several cell lines.
Wu SM; Ren QG; Zhou MO; Wei Y; Chen JY
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Jul; 35(7):655-60. PubMed ID: 12883637
[TBL] [Abstract][Full Text] [Related]
8. Human glioblastoma stem-like cells accumulate protoporphyrin IX when subjected to exogenous 5-aminolaevulinic acid, rendering them sensitive to photodynamic treatment.
Schimanski A; Ebbert L; Sabel MC; Finocchiaro G; Lamszus K; Ewelt C; Etminan N; Fischer JC; Sorg RV
J Photochem Photobiol B; 2016 Oct; 163():203-10. PubMed ID: 27588717
[TBL] [Abstract][Full Text] [Related]
9. Calcitriol enhances 5-aminolevulinic acid-induced fluorescence and the effect of photodynamic therapy in human glioma.
Chen X; Wang C; Teng L; Liu Y; Chen X; Yang G; Wang L; Liu H; Liu Z; Zhang D; Zhang Y; Guan H; Li X; Fu C; Zhao B; Yin F; Zhao S
Acta Oncol; 2014 Mar; 53(3):405-13. PubMed ID: 24032442
[TBL] [Abstract][Full Text] [Related]
10. Low-dose arsenic trioxide enhances 5-aminolevulinic acid-induced PpIX accumulation and efficacy of photodynamic therapy in human glioma.
Wang C; Chen X; Wu J; Liu H; Ji Z; Shi H; Gao C; Han D; Wang L; Liu Y; Yang G; Fu C; Li H; Zhang D; Liu Z; Li X; Yin F; Zhao S
J Photochem Photobiol B; 2013 Oct; 127():61-7. PubMed ID: 23962849
[TBL] [Abstract][Full Text] [Related]
11. Dormant cancer cells accumulate high protoporphyrin IX levels and are sensitive to 5-aminolevulinic acid-based photodynamic therapy.
Nakayama T; Otsuka S; Kobayashi T; Okajima H; Matsumoto K; Hagiya Y; Inoue K; Shuin T; Nakajima M; Tanaka T; Ogura SI
Sci Rep; 2016 Nov; 6():36478. PubMed ID: 27857072
[TBL] [Abstract][Full Text] [Related]
12. Identification and pharmacological modification of resistance mechanisms to protoporphyrin-mediated photodynamic therapy in human cutaneous squamous cell carcinoma cell lines.
Schary N; Novak B; Kämper L; Yousf A; Lübbert H
Photodiagnosis Photodyn Ther; 2022 Sep; 39():103004. PubMed ID: 35811052
[TBL] [Abstract][Full Text] [Related]
13. Differentiation enhances aminolevulinic acid-dependent photodynamic treatment of LNCaP prostate cancer cells.
Ortel B; Sharlin D; O'Donnell D; Sinha AK; Maytin EV; Hasan T
Br J Cancer; 2002 Nov; 87(11):1321-7. PubMed ID: 12439724
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of the effect of 5-aminolevulinic acid-based photodynamic therapy by simultaneous hyperthermia.
Yanase S; Nomura J; Matsumura Y; Nagai K; Kinoshita M; Nakanishi H; Ohnishi Y; Tokuda T; Tagawa T
Int J Oncol; 2005 Jul; 27(1):193-201. PubMed ID: 15942660
[TBL] [Abstract][Full Text] [Related]
15. Cell specific effects of polyunsaturated fatty acids on 5-aminolevulinic acid based photosensitization.
Gederaas OA; Schønberg SA; Ramstad S; Berg K; Johnsson A; Krokan HE
Photochem Photobiol Sci; 2005 Apr; 4(4):383-9. PubMed ID: 15803209
[TBL] [Abstract][Full Text] [Related]
16. Etretinate enhances the susceptibility of human skin squamous cell carcinoma cells to 5-aminolaevulic acid-based photodynamic therapy.
Ishida N; Watanabe D; Akita Y; Nakano A; Yamashita N; Kuhara T; Yanagishita T; Takeo T; Tamada Y; Matsumoto Y
Clin Exp Dermatol; 2009 Apr; 34(3):385-9. PubMed ID: 19077103
[TBL] [Abstract][Full Text] [Related]
17. Subcellular localization pattern of protoporphyrin IX is an important determinant for its photodynamic efficiency of human carcinoma and normal cell lines.
Ji Z; Yang G; Vasovic V; Cunderlikova B; Suo Z; Nesland JM; Peng Q
J Photochem Photobiol B; 2006 Sep; 84(3):213-20. PubMed ID: 16709459
[TBL] [Abstract][Full Text] [Related]
18. Small molecule kinase inhibitors enhance aminolevulinic acid-mediated protoporphyrin IX fluorescence and PDT response in triple negative breast cancer cell lines.
Palasuberniam P; Kraus D; Mansi M; Howley R; Braun A; Myers K; Chen B
J Biomed Opt; 2021 Sep; 26(9):. PubMed ID: 34545713
[TBL] [Abstract][Full Text] [Related]
19. Novel potential photodynamic therapy strategy using 5-Aminolevulinic acid for ovarian clear-cell carcinoma.
Teshigawara T; Mizuno M; Ishii T; Kitajima Y; Utsumi F; Sakata J; Kajiyama H; Shibata K; Ishizuka M; Kikkawa F
Photodiagnosis Photodyn Ther; 2018 Mar; 21():121-127. PubMed ID: 29196245
[TBL] [Abstract][Full Text] [Related]
20. Anticancer effect of photodynamic therapy with hexenyl ester of 5-aminolevulinic acid in oral squamous cell carcinoma.
Moon YH; Park JH; Kim SA; Lee JB; Ahn SG; Yoon JH
Head Neck; 2010 Sep; 32(9):1136-42. PubMed ID: 19953630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]